INHERIT scans NIH, NSF, DOE, NASA, and DARPA awards in real time, then tells you which research is licensable, which markets are wide open, and which gaps are yours to ship.
No credit card. Run your first remix in 90 seconds.
Where to begin
For when you have 4 hours on Saturday and want to leave with something real. INHERIT surfaces the highest-fit research asset with code, the PI to email, and a draft message in your voice.
Search
Open in canvas
Searching “cancer immunotherapy”
This is what Maya sees on Saturday morning.
The real problem
Y Combinator's startup ideas page. Hacker News. AI Twitter. Indie Hackers. Every founder is reading the same 47 tabs.
Meanwhile, $89B of federally-funded research sits in NIH RePORTER, NSF Awards, and DOE OSTI — peer-reviewed, IP-protected, often commercialization-ready, and almost never licensed.
The next defensible company isn't in your reading list. It's in the gap between what's been funded and what's been built.
Most founders spend 6–18 months wandering. You don't have to.
The index
When a PI's grant ends, when a paper hits 100 citations, when a patent expires — INHERIT sees it the next morning.
One take. Nothing edited. The deck at the end is real.
How it works
01Find
Type a sector. INHERIT ranks every relevant federal project by commercialization fit — composite score, team strength, citation velocity, code availability. The top result is often a multi-million-dollar NIH grant nobody's licensed.
02Pressure-test
Every gap gets a market, technical, and commercial critique. The waveform shows you which dimensions are strong — and which kill the thesis before you waste a week on it.
03Ship
Click "draft outreach." INHERIT writes a cold email in your voice, citing the PI's actual grant, the paper's actual citations, the gap's actual evidence. Then it generates the deck, the memo, the one-pager.
Draft outreach
To:Dr. Alana Chen · Memorial Sloan Kettering
Subject:Licensing path for your engineered TCR repertoire work (1R01CA228116)
Dr. Chen — I came across your NIH/NCI R01 on engineered TCR libraries for HLA-A*02 neoantigens (1R01CA228116, $4.8M, expiring Q4) and the Phase 1 data your group released in April. The licensing window looks open and your published code is unusually production-ready. I'm exploring a translational wedge in solid-tumor TCR delivery and would love 20 minutes to discuss whether the repertoire IP is available for an exclusive field-of-use license. Free Thursday or Friday next week?
By Saturday afternoon you have a thesis. By Sunday you have a PI on the calendar.
Every artifact INHERIT generates names the IP, the funding source, and the freshness — so “why now” answers itself.
Workspace stitches every asset you saved into a thesis you can hand to your committee.
ChatGPT hallucinates the market.
INHERIT cites NIH grant 1R01CA228116 — $4.8M, expires Q4 — and the PI's published code.
ChatGPT generates ideas you can already find on Twitter.
INHERIT surfaces research nobody’s licensed yet, ranked by commercialization fit.
ChatGPT writes generic outreach.
INHERIT writes outreach in your voice, citing the PI’s actual grant and code.
ChatGPT forgets you between sessions.
INHERIT remembers every remix, every artifact, every voice — and sharpens with use.
General-purpose AI is a thinking partner. INHERIT is a building partner.
First 500 founders lock in $19/month for life.
347 spots remaining
Type a sector. Get a startup hypothesis with the PI to email by Sunday. No credit card.
Start free347 of 500 launch spots remaining